Shah Capital urges Novavax shareholders to vote against three directors
(Adds details from the company’s proxy filing in paragraph 6) May 6 (Reuters) – Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and proposals related to executive compensation, weeks after pushing for a board shakeup at the COVID-19 vaccine maker. Shah Capital, the biotech’s third-largest shareholder … Read more